Sale of shares in Renalytix AI plc
EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that it has sold 1,675,000 ordinary shares in Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) at a price of £4.60 per ordinary share, in response to strong institutional demand. The sale has resulted in gross proceeds of £7.705m to EKF and generated a profit of over £5.6m after dealing expenses.
Following this transaction EKF will continue to hold 1,002,981 ordinary shares in Renalytix AI plc.
Enquiries:
EKF Diagnostics Holdings plc |
www.ekfdiagnostics.com Tel: 00 44 29 2071 0570 |
N+1 Singer (Nomad & Broker)
Aubrey Powell / Lauren Kettle / George Tzimas (Corporate Finance) Tom Salvesen (Corporate Broking) |
Tel: 020 7496 3000 |
Walbrook PR Limited |
Tel: 020 7933 8780 or Mob: 07980 541 893 / 07584 391 303 |
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.